Search research articles
Contact Us
Filters
Showing results (81-90 of 256) with videos related to
Page
of 26
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2014
Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar
William C Kreisl, Ritwik Bhatia, Cheryl L Morse, et al.
ACS Chemical Neuroscience
|
April 22, 2018
3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 1: Synthesis and Pharmacology
Prachi Singh, Stal Shrestha, Michelle Y Cortes-Salva, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 5, 2006
Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans
Vanessa L Cropley, Masahiro Fujita, John L Musachio, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 23, 2008
Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain
H Umesha Shetty, Sami S Zoghbi, Fabrice G Siméon, et al.
ACS Chemical Neuroscience
|
December 14, 2016
Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
Frederick A Schroeder, Tonya M Gilbert, Ningping Feng, et al.
ACS Chemical Neuroscience
|
July 11, 2012
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)
Pavitra Kannan, Sanjay Telu, Suneet Shukla, et al.
Psychopharmacology
|
August 10, 2006
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
Nicholas Seneca, Balázs Gulyás, Andrea Varrone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2008
11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux
Sami S Zoghbi, Jeih-San Liow, Fumihiko Yasuno, et al.
Bioconjugate Chemistry
|
January 17, 2002
Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter
Richard R Cesati, Gilles Tamagnan, Ronald M Baldwin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
Akira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Page
of 26
Search research articles
Search
Showing results (81-90 of 256) with videos related to
Sort By:
Page
of 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2014
Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar
William C Kreisl, Ritwik Bhatia, Cheryl L Morse, et al.
ACS Chemical Neuroscience
|
April 22, 2018
3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 1: Synthesis and Pharmacology
Prachi Singh, Stal Shrestha, Michelle Y Cortes-Salva, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 5, 2006
Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans
Vanessa L Cropley, Masahiro Fujita, John L Musachio, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 23, 2008
Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain
H Umesha Shetty, Sami S Zoghbi, Fabrice G Siméon, et al.
ACS Chemical Neuroscience
|
December 14, 2016
Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
Frederick A Schroeder, Tonya M Gilbert, Ningping Feng, et al.
ACS Chemical Neuroscience
|
July 11, 2012
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)
Pavitra Kannan, Sanjay Telu, Suneet Shukla, et al.
Psychopharmacology
|
August 10, 2006
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
Nicholas Seneca, Balázs Gulyás, Andrea Varrone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2008
11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux
Sami S Zoghbi, Jeih-San Liow, Fumihiko Yasuno, et al.
Bioconjugate Chemistry
|
January 17, 2002
Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter
Richard R Cesati, Gilles Tamagnan, Ronald M Baldwin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
Akira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Page
of 26